ALK and anaplastic large cell lymphoma: Passoni et al. further reasoned that since in ALCL, the strong NPM promoter should drive high levels of NPM-ALK fusion protein expression and proteasome processing, high levels of ALK epitopes would likely be exposed to our immune system to trigger tumor-specific CTL responses.